Nicolas Leupin, Former Chief Medical Officer at NovoCure Ltd (NVCR), sold 1,100 shares at $13.31 ($15K) on 2026-03-04, disclosed to the SEC on 2026-03-05.
Open-market sale of $15k NVCR by Former Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |